Drawing for PGI

USPTO serial 97679506

PGI

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
KEAM, ALEX S
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with PGI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa Greenwald-Swire

Lisa Greenwald-Swire Fish & Richardson P.C.PO Box 1022Minneapolis, MN 55440-1022United States

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for scientific use for use in gene therapy, gene editing, gene insertion, and cell therapyACTIVE—
005Pharmaceutical preparations and biological preparations for medical treatment for use in gene therapy, gene editing, gene insertion, and cell therapy for the treatment of genetic disorders; Pharmaceutical and biological preparations for the treatment of genetic disorders; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, modification, regulation, and repair for use in human therapeuticsACTIVE—
042Medical and scientific research; Medical research and development in the fields of genomic medicine, genome engineering, and cell engineering; Scientific research and development in the field of genomic medicine, genome engineering, and cell engineering; Research and development of pharmaceutical preparations for gene therapy, gene editing, gene insertion, and cell therapy; Providing medical and scientific research information in the fields of genomic medicine, genome engineering, and cell engineeringACTIVE—
044Providing medical and healthcare information in the field of gene sequencing, gene editing, and gene insertion technologies; Providing medical and healthcare information regarding gene therapies and cell therapiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 26, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 25, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 24, 2026EXT5SOU EXTENSION 5 FILED—
Aug 24, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 2, 2026EX4GSOU EXTENSION 4 GRANTED—
Mar 2, 2026EXT4SOU EXTENSION 4 FILED—
Mar 2, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 30, 2025EX3GSOU EXTENSION 3 GRANTED—
Jul 30, 2025EXT3SOU EXTENSION 3 FILED—
Jul 30, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 2, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 1, 2025EX2GSOU EXTENSION 2 GRANTED—
Jun 24, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 17, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 17, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 17, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 5, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXT2SOU EXTENSION 2 FILED—
Sep 5, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 5, 2024EX1GSOU EXTENSION 1 GRANTED—
Sep 5, 2024EXT1SOU EXTENSION 1 FILED—
Sep 5, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 5, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 9, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 9, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 20, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 2, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 2, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Dec 2, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 2, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 2, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 28, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 27, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 27, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 29, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2023DOCKASSIGNED TO EXAMINER—
Dec 8, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 19, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance